This product is a DG-75 [D.G.-75] B cell engineering tool based on the Quantum dots (Dexamethasone/Glucocorticoid receptor) delivery system and CRISPR-based (AAVS1-crRNA:tracrRNA duplex-SpCas9-(Z)-4-Hydroxytamoxifen ) genome editor.
| Host Cell | DG-75 [D.G.-75] |
| Target | AFP |
| Insert Clone | 3B10 |
| Safe Harbor Sites (SHS) | AAVS1 |
| gRNA | crRNA:tracrRNA duplex |
| Nuclease | SpCas9 |
| Enhancer | (Z)-4-Hydroxytamoxifen |
| Targeting Strategy | Enzyme responsive, time-dependent |
| Insertion sites | Unproductive heavy chain |
| Vehicles | Quantum dots |
| Ligand/Receptor | Dexamethasone/Glucocorticoid receptor |
| Active Agents | ESC8 |
| Particle Size | 20-150 |
| Charge (mv) | 17 to 58 |
| Total Atom Count | ~60,000,000 |
| Surface Atoms (%) | ~0.8 |
| Specific Surface Area (m2/g) | ~2.5 |
| Vector Type | Lentivirus |
| Vector Name | BCpCDH2 |
| Targeting Diseases | Breast cancer; Colon cancer; Lung cancer; Ovarian cancer |
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.